Public Health Agency of Canada

This page is a summary of National Advisory Committee on Immunization (NACI) statement: Recommendations on the use of COVID-19 vaccines.

This evergreen document will be updated as COVID-19 vaccines are authorized and become available for use in Canada, and as evidence on these vaccines and COVID-19 evolves. This table summarizes the latest changes to this current version. Please refer to the Table of updates for a full list of...

Public Health Agency of Canada (PHAC)’s landing page for multiple public health surveillance programs.

This is the third report of the Public Health Agency of Canada's (PHAC) Injury in Review series, providing important national surveillance statistics on the causes of traumatic brain injuries (TBI) across the life course, including sports, seniors' falls, assaults, consumer products, and more.

3,673 isolates causing invasive pneumococcal disease (IPD) were characterized in 2019. Incidence rate of IPD for 2019 for children under <1 year of age is 13.2 cases per 100,000 population and for seniors ≥60 years to 21.2 cases per 100,000 population. The overall crude incidence rate has...

This statement contains NACI’s independent advice and recommendations, which are based upon the best current available scientific knowledge. This document is being disseminated for information purposes. People administering the vaccine should also be aware of the contents of the relevant product...

The national incidence of foodborne pathogens is actively collected and reported by the National Enteric Surveillance Program (NESP). The NESP has been in operation since April 1997 and is designed to provide timely analysis and reporting of laboratory confirmed enteric disease cases in Canada.

The National Advisory Committee on Immunization (NACI) is an External Advisory Body that provides the Public Health Agency of Canada (PHAC) with independent, ongoing and timely medical, scientific, and public health advice in response to questions from PHAC relating to immunization. This...

Canada's National Microbiology Laboratory (NML) is known around the world for its scientific excellence. We work with public health partners in Canada and abroad to prevent the spread of infectious diseases. Main functions are: research, lab-based surveillance, emergency preparedness and...

This document outlines the recommended goals, objectives, and activities for COVID-19 surveillance in Canada. These guidelines are based on current available scientific evidence and expert opinion and are subject to change as new information becomes available. They should be read in conjunction...

Annual recommendations on the use of influenza vaccine in Canada are developed by the NACI Influenza Working Group (IWG) for consideration by NACI. Recommendations are developed based on a review of a variety of issues, which can include: the burden of influenza illness and the target populations...

Advice on pregnancy, childbirth, breastfeeding and having visitors during the COVID-19 pandemic.

The Public Health Agency of Canada, in collaboration with provincial and territorial public health authorities, established the Canadian SARS-CoV-2 Variant Surveillance Group (CSVSG) to monitor and assess the impact of variants of SARS-CoV-2 on viral transmissibility, disease severity, and...

The objective of the Interim National Vaccine Storage, Handling and Transportation Guidelines for Ultra-Low Temperature and Frozen Temperature COVID-19 Vaccines – 2021 is to supplement and update the guidance for storage, handling and transportation of ultra-low temperature and frozen temperature...

Canadians can access comprehensive information and resources on COVID-19 on the Government of Canada coronavirus disease website Canada.ca/coronavirus, including updates on the current situation, self-assessment and mental and physical health resources. The website also provides guidance on...